SCHEMBL1448946

SCHEMBL1448946

CN(C)C=CC(=O)c1cccc(P(c2cccc(C(=O)C=CN(C)C)c2)c2cccc(C(=O)C=CN(C)C)c2)c1

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.65
ALDH1A1 P00352 10/20 0.65
HTT P42858 4/20 0.65
GAA P10253 3/20 0.65
HPGD P15428 3/20 0.65
RECQL P46063 2/20 0.62
RAB9A P51151 5/20 0.58
LMNA P02545 3/20 0.51
CYP1A2 P05177 2/20 0.50
CYP2C19 P33261 2/20 0.50
ALOX12 P18054 1/20 0.50
TDP1 Q9NUW8 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.48
NPC1 O15118 3/20 0.48
POLB P06746 2/20 0.48
HSP90AA1 P07900 1/20 0.48
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1449217 0.95 RECQL (0.66) MAPTALDH1A1HTTGAAHPGD
SCHEMBL14063274 0.95 RECQL (0.66) MAPTALDH1A1HTTGAAHPGD
SCHEMBL12742903 0.95 RECQL (0.66) MAPTALDH1A1HTTGAAHPGD
SCHEMBL5946453 0.86 MAPT (0.77) MAPTALDH1A1HTTGAAHPGD
SCHEMBL12742925 0.85 MAPT (0.58) MAPTALDH1A1HTTGAAHPGD
SCHEMBL12742913 0.81 RECQL (0.72) MAPTALDH1A1HTTGAAHPGD
SCHEMBL1448532 0.81 RECQL (0.72) MAPTALDH1A1HTTGAAHPGD
SCHEMBL22449502 0.80 RECQL (0.71) MAPTALDH1A1HTTGAAHPGD
SCHEMBL2945499 0.80 MAPT (0.69) MAPTALDH1A1HTTGAAHPGD
SCHEMBL5646420 0.80 MAPT (0.69) MAPTALDH1A1HTTGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7910744-B2 Pyrazole and Pyrimidine groups are introduced on aromatic phosphine; (3-bromophenyl)methyl ketone and ethylene glycol cyclize to [3-(2-methyl-1,3-dioxolane-2-yl)phenyl]diphenylphosphane; adding hydrazine monohydrate, then oxidizing with hydrogen peroxide; [3-(3-Pyrazolyl)phenyl]diphenylphosphane oxide ZYLUM BETEILIGUNGSGESELLSCHAFT MBH & CO. PATENT II KG (DE) 2011-03-22 US disclosed
EP-1805193-B1 METHOD FOR THE PRODUCTION OF SUBSTITUTED PHOSPHANES ZYLUM BETEILIGUNGSGMBH & CO PATENTE II KG (DE) 2010-12-29 EP disclosed
US-20080221335-A1 Method for the Manufacture of Substituted Phosphanes, and Substituted Phosphanes Manufactured According to Said Method ZYLUM BETEILIGUNGSGESELLSCHAFT MBH & CO. PATENTE II KG (DE) 2008-09-11 US disclosed
EP-1805193-A1 METHOD FOR THE PRODUCTION OF SUBSTITUTED PHOSPHANES, AND SUBSTITUTED PHOSPHANES PRODUCED ACCORDING TO SAID METHOD Technische Universität Chemnitz (DE) 2007-07-11 EP disclosed
WO-2006045272-A1 METHOD FOR THE PRODUCTION OF SUBSTITUTED PHOSPHANES, AND SUBSTITUTED PHOSPHANES PRODUCED ACCORDING TO SAID METHOD TECHNISCHE UNIVERSITÄT CHEMNITZ (DE) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221335-A1 Method for the Manufacture of Substituted Phosphanes, and Substituted Phosphanes Manufactured According to Said Method SCLY, SELENOI, TST MAPT 4444/4885ALDH1A1 1760/4885HTT 2626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.